Stock screenerAll disclosures →
EDGAR →
MLTX
Conviction 65HealthcareScan · Mon, Aug 10, 2026MLTX$17.35-4.98%
ResistanceSupportVol 14Insider sellVol MA14 1.09M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price17.35
Change-4.98%
Gap-5.61%
Rel volume4.92×
Avg volume1.07M
Avg $ vol19.77M
SMA 2018.78
SMA 5019.02
SMA 20016.42
Price vs 50-8.79%
Price vs 200+5.68%
MA stackmixed
50/200 cross—
Supertrenddown · 20.02
RSI (14)41
MACD hist-0.16
MACD cross—
Stoch %K / %D24 / 28
ADX (14)16
+DI / −DI14 / 26
RSI divergence—
MACD divergence—
ATR %+5.69%
ADR %4.99%
52w high61.99
52w low6.25
From 52w high-72.01%
Above 52w low+177.82%
New 52w highNo
SqueezeOff
Bollinger width17.49%
%B0.07
Donchian pos20.05%
Donchian high20.62
Donchian low16.53
AVWAP (52w high)12.47
vs AVWAP high+39.15%
AVWAP (52w low)12.37
vs AVWAP low+40.26%
OBV trendDown
Chaikin MF (20)-0.03
Today vs 20d4.92×
Avg vol (14d)1.09M
Avg vol (20d)1.07M
Avg $ vol (20d)19.77M
Market cap—
RS 3m (vs SPY)+0.47%
RS 6m (vs SPY)+9.51%
RS line new highNo
Trend template5/8
Technical rank42.5
1 week-0.29%
1 month-14.78%
3 months+1.70%
6 months+11.86%
1 year-66.56%
YTD+45.19%
P/E-5.91
P/B5.29
P/S—
P/FCF-6.85
EPS-3.53
Div yield—
ROE-89.49%
ROA-56.78%
Debt/Eq0.39
Current8.60
EV/EBITDA-4.72
Gross margin—
Net margin—
Rev growth—
EPS growth-91.13%
Price target34.44
Target upside88.66%
Analyst ratingBuy
Institutional76.53%
Ent. value1.14B
Revenue—
Net income-69.71M
Gross profit—
Free cash flow-196.04M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out73.62M
Employees130
ListedWed, Apr 6, 2022
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction65 / 100
Pattern quality—
Tech rank42.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance22.29
Support17.87
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MLTX
No recent disclosed trades by Congress in MLTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MLTX · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Santos da Silva Jorge Chief Executive Officer · Class A ordinary shares, par value $0.0001 per share · 2026-07-10 | Sell | 68.29K | $1.4M | 2026-07-10 | 2026-07-13 |
Santos da Silva Jorge Chief Executive Officer · Class A ordinary shares, par value $0.0001 per share · 2026-07-09 | Sell | 33.94K | $679K | 2026-07-09 | 2026-07-13 |
BVF PARTNERS L P/IL Director · Option to Buy · 2026-06-17 | Grant | 22.2K | — | 2026-06-17 | 2026-06-22 |
Bodenstedt Matthias Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-06-18 | Sell | 2.79K | $55K | 2026-06-18 | 2026-06-18 |
Phillips Andrew John Director · Option to Buy · 2026-06-17 | Grant | 22.2K | — | 2026-06-17 | 2026-06-18 |
Moukheibir Catherine Director · Option to Buy · 2026-06-17 | Grant | 22.2K | — | 2026-06-17 | 2026-06-18 |
Xavier Ramnik Director · Option to Buy · 2026-06-17 | Grant | 22.2K | — | 2026-06-17 | 2026-06-18 |
Bodenstedt Matthias Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-06-17 | Sell | 15.08K | $297K | 2026-06-17 | 2026-06-18 |
Loy Spike Director · Option to Buy · 2026-06-17 | Grant | 22.2K | — | 2026-06-17 | 2026-06-18 |
Bodenstedt Matthias Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-05-11 | Sell | 13.65K | $273K | 2026-05-11 | 2026-05-13 |
SEC filings
EDGAR filings in MLTX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.